06548nam 2202065z- 450 991055730950332120231214133513.0(CKB)5400000000042761(oapen)https://directory.doabooks.org/handle/20.500.12854/68463(EXLCZ)99540000000004276120202105d2021 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierRole of Medical Imaging in CancersVolume 2Basel, SwitzerlandMDPI - Multidisciplinary Digital Publishing Institute20211 electronic resource (228 p.)3-0365-0206-8 3-0365-0207-6 The issue of Cancers Journal entitled “Role of Medical Imaging in Cancers” presents a detailed summary of evidences about molecular imaging, including the role of computed tomography (CT), magnetic resonance imaging (MRI), single photon emission tomography (SPET) and positron emission tomography (PET) or PET/CT or PET/MR imaging in many type of tumors (i.e. sarcoma, prostate, breast and others), motivating the role of these imaging modalities in different setting of disease and showing the recent developments, in terms of radiopharmaceuticals, software and artificial intelligence in this field. The collection of articles is very useful for many specialists, because it has been conceived for a multidisciplinary point of view, in order to drive to a personalized medicine.Medicinepositron emission tomographyhead and neck neoplasmsneovascularizationpathologicPET/CTurothelial carcinomabladder cancerupper tract urothelial carcinomasurvivalPETPSMAprostateDCFPyLDCFBCPSMA-1007ovarian cancerrelapseSUVmaxtargeted therapyprognosissoft tissue sarcoma (STS)pazopanibdynamic 18F-FDG PET/CTSUVtwo-tissue compartment modelmagnetic resonance imagingmachine learningdiffusionperfusiontexture analysissquamous cell carcinoma of the head and neckdiffusion-weighted imagingmalignant pleural mesotheliomapleural disseminationempyemapleural effusionmCRPCSPECT/CTComputer-assisted diagnosisXOFIGOTherapy response assessmentcirculating miRNAsbreast cancerimaging parametersPET/MRIbiomarkerstriple negative breast cancerVCAM-1SPECT imagingsdAbsHounsfield unitcomputed tomographyadipose tissueprecision oncologyFDG-PET/CTPERCISTmetastatic breast cancerprostate cancer18F-FACBCrecurrencemeta-analysisreviewmeningiomasomatostatin receptorneuroimagingradionuclide therapybreastimagingmarkerradiomicsYin Yang 1PDACMesothelinnoninvasive imagingreceptor statusmolecular imagingnuclear medicineguidelinesoverutilizationepistemologyconsensusmantle cell lymphoma18F-FDG PET/CTDeauville criteriaRadium-223FDGcastrate resistant prostate cancerprogrammed cell death 1 receptordiagnostic imagingCTLA-4 AntigenImmunotherapyAdoptiveradioactive tracersradionuclide imagingCD8-Positive T-LymphocytesPI-RADSdiffusion kurtosis imagingdynamic contrast-enhanced magnetic resonance imaging68Gallium-PSMA PET/CTprostate-specific-antigenPSA kinetics thresholdsbiochemical recurrenceoptimal cutoff levelnon-small-cell lung cancercirculating tumor cellsimmunotherapyresponse to treatmenthead and neck cancerHPVEBVp16Molecular imagingmiRNA expressionradiogenomicsradiomicdiagnosisbiomarkerglioblastomaradiation therapyMRIdiffusion tensor imagingHodgkin lymphomadiffuse large B-cell lymphomastagingresponse assessmentlocally advanced cervical cancerconcurrent chemoradiotherapytreatment responsefollow upcystic tumorInternational Consensus Guidelinesintraductal papillary mucinous neoplasmspancreatic neoplasmsPD-1PD-L1response to therapyNSCLCpositron-emission tomographysingle-photon emission computed tomographyimmune checkpoint inhibitorsgold nanoparticleheat shock protein 70spectral-CTMedicine.Fanti Stefanoedt755618Evangelista LauraedtFanti StefanoothEvangelista LauraothBOOK9910557309503321Role of Medical Imaging in Cancers3024548UNINA